Interobserver Reproducibility of Her-2/neu Protein Overexpression in Invasive Breast Carcinoma Using the DAKO HercepTest
Open Access
- 1 November 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 118 (5), 693-698
- https://doi.org/10.1309/6anb-qxcf-ehkc-7uc7
Abstract
Although there are criteria for interpretation of the staining results for Her-2/neu in the DAKO HercepTest, the determination of staining intensityKeywords
This publication has 24 references indexed in Scilit:
- HER2 Testing in Patients With Breast Cancer: Poor Correlation Between Weak Positivity by Immunohistochemistry and Gene Amplification by Fluorescence In Situ HybridizationMayo Clinic Proceedings, 2002
- Current Status of HER2 TestingAmerican Journal of Clinical Pathology, 2001
- Assessment of HER-2/neu Status in Breast CancerAmerican Journal of Clinical Pathology, 2001
- HER-2/neu Testing in Breast Carcinoma: A Combined Immunohistochemical and Fluorescence In Situ Hybridization ApproachLaboratory Investigation, 2000
- Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assaysJournal of Clinical Pathology, 2000
- Sensitivity of HER-2/neu Antibodies in Archival Tissue Samples of Invasive Breast CarcinomasAmerican Journal of Clinical Pathology, 2000
- Biotechnology UpdateJournal of the American Pharmaceutical Association, 1999
- C-erbB-2 immunostaining: problems with interpretation.Journal of Clinical Pathology, 1994
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987